Stocks›Healthcare›IDXX

IDXX

Idexx Laboratories Inc /de

NasdaqResearch view

Idexx Laboratories Inc /de operates in the In Vitro & In Vivo Diagnostic Substances industry.

$515.41−2.21%

Oct 6 close · 1D EOD · Databento

HealthcareIn Vitro & In Vivo Diagnostic SubstancesLarge-capSEC EDGAR FY 2025-12-31

What happened

Daily closes · dots are Wire stories

What’s next

Expected around early November, going by its own filing history. The company has not announced a date yet. Its matching report came Nov 3, 2025 and Oct 31, 2024, before the open.

Last report

Aug 4, 2026+3.57%

before the open

Last 4, next close

median 4.08% either way

up 2 of 4

Every report since 2022 →Earnings calendar →

DateEventSourceNext close

Aug 4Earnings release, before the open · 8-KSEC EDGARSEC EDGAR ↗+3.57%

Next close = the first close after the event against the close before it. Prior-session closes only; not a call, not advice.

What happened · big days

23 big days in a year, and what we hold on each

A big day is a close more than 3.12% from the one before, three times IDXX’s median day (1.04%). On 6 of the 23, its peer group moved the same way at least half as far. We show what we hold. We never name a cause.

every other trading daya big day, numbered in the list below±3.12%Hover a bar for its day. Click a big day to open it.

Shaded: since our stories began, Jun 10. Tap a bar for its day.

#DayIDXXWhat we hold that dayGroup (median of 4) · each

1 Nov 3, 2025+14.84%
Resultsgroup +0.2%, did not move with it
1Nov 3, 2025+14.84%
ResultsFirst close after the Nov 3 results filing
+0.2% did not move with itNTLA +3.6 · NEOG +1.9 · LNTH −1.5 · CLDX −7.4
2 Nov 19, 2025+4.01%
Before our storiesgroup −2.6%, did not move with it
2Nov 19, 2025+4.01%
Before our stories
−2.6% did not move with itLNTH −1.3 · CLDX −2.6 · NTLA −2.7 · NEOG −5.9
3 Nov 21, 2025+5.30%
Before our storiesgroup +3.8%, moved with IDXX
3Nov 21, 2025+5.30%
Before our stories
+3.8% moved with IDXXNEOG +5.7 · LNTH +4.2 · CLDX +3.4 · NTLA +2.1
4 Nov 24, 2025+3.61%
Before our storiesgroup +1.6%, did not move with it
4Nov 24, 2025+3.61%
Before our stories
+1.6% did not move with itNEOG +2.5 · NTLA +1.7 · CLDX +1.5 · LNTH +1.2
5 Dec 1, 2025−3.18%
Before our storiesgroup −2.5%, moved with IDXX
5Dec 1, 2025−3.18%
Before our stories
−2.5% moved with IDXXNTLA −6.3 · CLDX −4.1 · NEOG −1.0 · LNTH +0.4
6 Jan 6, 2026+3.61%
Before our storiesgroup +2.4%, moved with IDXX
6Jan 6, 2026+3.61%
Before our stories
+2.4% moved with IDXXNTLA +3.8 · CLDX +2.7 · NEOG +2.1 · LNTH +1.0
7 Jan 20, 2026−4.10%
Before our storiesgroup +1.8%, did not move with it
7Jan 20, 2026−4.10%
Before our stories
+1.8% did not move with itCLDX −2.0 · NEOG +1.1 · LNTH +2.5 · NTLA +2.6
8 Feb 2, 2026−4.60%
Resultsgroup −0.2%, did not move with it
8Feb 2, 2026−4.60%
ResultsFirst close after the Feb 2 results filing
−0.2% did not move with itNTLA −0.7 · LNTH −0.6 · CLDX +0.2 · NEOG +0.3
9 Feb 12, 2026−4.86%
Before our storiesgroup −1.4%, did not move with it
9Feb 12, 2026−4.86%
Before our stories
−1.4% did not move with itCLDX −4.2 · NTLA −3.2 · NEOG +0.3 · LNTH +2.1
10 Feb 24, 2026+4.19%
Before our storiesgroup +1.7%, did not move with it
10Feb 24, 2026+4.19%
Before our stories
+1.7% did not move with itNTLA +3.2 · CLDX +2.1 · NEOG +1.2 · LNTH +0.3
11 Mar 5, 2026−4.59%
Before our storiesgroup −1.5%, did not move with it
11Mar 5, 2026−4.59%
Before our stories
−1.5% did not move with itNTLA −4.8 · LNTH −2.0 · NEOG −1.0 · CLDX −0.6
12 Mar 12, 2026−4.88%
Before our storiesgroup −3.5%, moved with IDXX
12Mar 12, 2026−4.88%
Before our stories
−3.5% moved with IDXXNEOG −5.2 · CLDX −4.3 · LNTH −2.7 · NTLA −1.2
13 Apr 10, 2026−3.72%
Before our storiesgroup −3.3%, moved with IDXX
13Apr 10, 2026−3.72%
Before our stories
−3.3% moved with IDXXNEOG −6.1 · CLDX −4.1 · NTLA −2.5 · LNTH −1.0
14 Apr 17, 2026+3.39%
Before our storiesgroup +2.5%, moved with IDXX
14Apr 17, 2026+3.39%
Before our stories
+2.5% moved with IDXXNTLA +5.6 · NEOG +2.9 · CLDX +2.0 · LNTH −0.1
15 May 11, 2026−5.02%
Before our storiesgroup −1.7%, did not move with it
15May 11, 2026−5.02%
Before our stories
−1.7% did not move with itCLDX −5.0 · NEOG −4.4 · LNTH +1.1 · NTLA +2.3
16 May 18, 2026+3.21%
Before our storiesgroup −2.2%, did not move with it
16May 18, 2026+3.21%
Before our stories
−2.2% did not move with itNEOG +4.5 · LNTH −0.8 · CLDX −3.6 · NTLA −7.2
17 Jun 9, 2026+3.16%
Before our storiesgroup +1.2%, did not move with it
17Jun 9, 2026+3.16%
Before our stories
+1.2% did not move with itCLDX +3.6 · NEOG +2.4 · LNTH −0.0 · NTLA −4.5
18 Jun 10, 2026−3.79%
Nothing on IDXXgroup −1.1%, did not move with it
18Jun 10, 2026−3.79%
Nothing on IDXXNo IDXX story, brief or results filing in our record that day
−1.1% did not move with itNTLA −5.3 · NEOG −1.3 · CLDX −0.8 · LNTH +0.3
19 Jun 17, 2026−4.70%
Nothing on IDXXgroup +0.1%, did not move with it
19Jun 17, 2026−4.70%
Nothing on IDXXNo IDXX story, brief or results filing in our record that day
+0.1% did not move with itNEOG −4.1 · LNTH −1.8 · CLDX +1.9 · NTLA +4.5
20 Jul 2, 2026+3.76%
Nothing on IDXXgroup +1.4%, did not move with it
20Jul 2, 2026+3.76%
Nothing on IDXXNo IDXX story, brief or results filing in our record that day
+1.4% did not move with itCLDX +4.3 · NTLA +1.9 · LNTH +0.8 · NEOG +0.3
21 Jul 14, 2026−4.17%
Nothing on IDXXgroup −0.4%, did not move with it
21Jul 14, 2026−4.17%
Nothing on IDXXNo IDXX story, brief or results filing in our record that day
−0.4% did not move with itLNTH −2.9 · CLDX −0.9 · NEOG +0.2 · NTLA +2.1
22 Jul 16, 2026+3.42%
Nothing on IDXXgroup −3.4%, did not move with it
22Jul 16, 2026+3.42%
Nothing on IDXXNo IDXX story, brief or results filing in our record that day
−3.4% did not move with itNEOG +3.5 · LNTH +0.8 · CLDX −7.6 · NTLA −9.1
23 Aug 4, 2026+3.57%
Resultsgroup +1.8%, did not move with it
23Aug 4, 2026+3.57%
ResultsFirst close after the Aug 4 results filing
+1.8% did not move with itNTLA +5.1 · CLDX +3.6 · LNTH −0.1 · NEOG −0.8

A story on the same day is not a cause, and a group move is not proof either. Group: the median of LNTH, NEOG, CLDX and NTLA that day, the largest companies in IDXX’s SEC industry; “moved with IDXX” means the same direction and at least half the size.

What’s next · results

Before the next report: what the first day after the last four did

Six trading days after each results filing (SEC 8-K, Item 2.02). IDXX reports before the open, so day 1 is that day’s close. Each time, day 6 ended on the same side as day 1.

Reported Nov 3, 2025

day 1+14.84%day 6+12.72%

Reported Feb 2, 2026

day 1−4.60%day 6−4.57%

Reported May 5, 2026

day 1−0.03%day 6−5.19%

Reported Aug 4, 2026

day 1+3.57%day 6+3.31%

Next report: expected early NovemberEstimated from the dates of its last four results filings. Not announced. Since the Aug 4 report: −7.18%. Four reports is a small sample.

Every report since 2022 →

Each line is IDXX’s close against its close before the filing, on licensed end-of-day closes. What happened after each report, not a forecast; a move on the day is not a cause.

The numbers · FY2025, filed

SEC EDGAR

Market cap$40.8B

Revenue$4.3B+10.40%

Net income$1.1B

EPS, diluted$13.08+22.60%

Gross margin61.8%

Operating margin31.6%

Return on equity66.0%

Debt / equity0.33

All filed figures

Snapshot

SEC EDGAR · FY 2025-12-31

SectorHealthcare

Market Cap$40.8B

Enterprise Value$41.2B

Income$1.1B

Sales$4.3B

Book/sh$20.38

Cash/sh$2.29

Dividend TTM—

Payout—

Employees—

IPO—

Quick Ratio0.90

Current Ratio1.23

Debt/Eq0.33

EPS (ttm)$13.08

EPS this Y22.6%

EPS past 3/5Y17.7%

Sales past 3/5Y8.5%

EPS Y/Y TTM22.6%

Sales Y/Y TTM10.4%

Shs Outstand78.78M

ROA31.6%

ROE66.0%

ROIC55.8%

Gross Margin61.8%

Oper. Margin31.6%

Profit Margin24.6%

Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue by fiscal year

$3.2B

FY21

$3.4B

FY22

$3.7B

FY23

$3.9B

FY24

$4.3B

FY25

Operating leverage — margins

GrossOperatingNet

Financials, annual · income and cash flowSEC EDGAR · open ▸

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it

USD	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$3.2B	$3.4B	$3.7B	$3.9B	$4.3B
Gross Profit	$1.9B	$2.0B	$2.2B	$2.4B	$2.7B
Operating Income	$932.0M	$898.8M	$1.1B	$1.1B	$1.4B
Net Income	$744.8M	$679.1M	$845.0M	$887.9M	$1.1B
Diluted EPS	$8.60	$8.03	$10.06	$10.67	$13.08
Operating Cash Flow	$755.5M	$543.0M	$906.5M	$929.0M	$1.2B
Free Cash Flow	$636.0M	$394.1M	$772.9M	$808.1M	$1.1B

Same industry

IDXX against four same-industry peers, a year at 100

IDXX is down 14.5% in a year. Neogen is up 2.2 times, Lantheus Holdings is up 87.1% and Celldex Therapeutics 21.7%. Of these four, only Intellia Therapeutics (−48.0%) did less. Weekly closes, Oct 10, 2025 = 100, on a log scale so a 2.2-fold rise and a 48.0% fall both read honestly.

Share this chart

IDXX −14.5%. Neogen ×2.2, Lantheus Holdings +87.1%, Celldex Therapeutics +21.7%, Intellia Therapeutics −48.0%. Weekly closes, Oct 10, 2025 = 100, log scale.

Share this chart

End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in IDXX’s SEC industry (In Vitro & In Vivo Diagnostic Substances) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.

Same industry

In the screener →

LNTH$6.5B NEOG$2.6B CLDX$2.5B NTLA$1.7B QDEL$739M TKNO$483M MYGN$434M NNNN$242M

Build basket with IDXX Screener

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.